CPH Cipher Pharmaceuticals Inc
- 8.350
- -0.040-0.48%
Cipher Pharmaceuticals Inc News
Press Release: Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON, June 14, 2024 MISSISSAUGA, ON, June 14, 2024 /CNW/ - Cipher Pharmaceuticals I
Cipher Pharmaceuticals Inc. Cut to Hold From Buy by Stifel Nicolaus
Cipher Pharmaceuticals Inc. Cut to Hold From Buy by Stifel Nicolaus
Cipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50
Stifel GMP on Monday downgraded its rating on the shares of Cipher Pharmaceuticals (CPH.TO) to hold from buy even as it raised its price target to C$9.50 from C$8.00 following a rise in the company's
Earnings Call Summary | Cipher Pharmaceuticals Inc(CPHRF.US) Q1 2024 Earnings Conference
The following is a summary of the Cipher Pharmaceuticals Inc. (CPHRF) Q1 2024 Earnings Call Transcript:Financial Performance:Cipher reported a total net revenue for Q1 2024 of $5.9 million, a 20% incr
Press Release: Cipher Pharmaceuticals Reports First Quarter 2024 Results
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire MISSISSAUGA, ON, May 9, 2024 (All figures are presented in U.S. Dollars) -- Adjusted EBITDA in Q1 2024 was $3.6 million
Stocks in Play: Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call
Cipher Pharmaceuticals Inc.'s (TSE:CPH) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which wil
Cipher Pharmaceuticals Q4 Profit Falls 61% on Charges
Cipher Pharmaceuticals (CPH.TO) on Thursday said its fourth-quarter profit fell 61% on charges. The company said it earned US$7.7 million, or US$0.32 per share, in the period, down from a profit of US
Cipher Pharmaceuticals Brief: Q4 Net Income and Earnings per Common Share Were US$7.7 Million and $0.32, Respectively
05:01 PM EDT, 03/14/2024 (MT Newswires) -- Cipher Pharmaceuticals Brief: Q4 Net income and earnings per common share were US$7.7 million and $0.32, respectively
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
Cipher Pharmaceuticals Inc. Raised to Buy From Speculative Buy by Citigroup
Cipher Pharmaceuticals Inc. Raised to Buy From Speculative Buy by Citigroup
Cipher Pharmaceuticals Upgraded to Buy at Stifel GMP; Price Target Raised to C$8.00
Stifel GMP on Wednesday upgraded its rating on the shares of Cipher Pharmaceuticals (CPH.TO) to buy from speculative buy and raised its price target to C$8.00 from C$4.75 for the specialty pharmaceuti
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading
OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX:OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cipher Pharmaceuticals Inc. (TSX:CPH,
Cipher Pharmaceuticals Announces Change of Auditor
Cipher Pharmaceuticals Brief: Announcing Normal Course Issuer Bid
05:00 PM EST, 11/15/2023 (MT Newswires) -- Cipher Pharmaceuticals Brief: Announcing Normal Course Issuer Bid
Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call
